MyFinsight
Home
Blog
About
Aquestive Therapeutics, Inc. (AQST)
Aquestive Therapeutics, Inc. (AQST)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Free Cash flow
-$9,653K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from issuance of long-t...
Loss on extinguishment of debt
Share-based compensation
Others
Negative Cash Flow Breakdown
Repayment of debt principal - 13...
Net loss
Premium paid to retire debt - 13...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-22,864
-8,057
-31,860
-15,446
Depreciation, amortization, and impairment
136
113
130
139
Gain on contract termination
-
-
0
0
Share-based compensation
2,895
2,318
1,376
2,777
Loss on extinguishment of debt
-11,683
-
-
-
Issuance of warrants
-
916
-
-
Issuance of warrants under the purchase agreement
916
-
-
-
Amortization of debt issuance costs and discounts
1,767
2,286
2,749
2,748
Other, net
-43
-6
-1
-11
Trade and other receivables, net
2,459
-10,896
5,959
-63
Inventories
-706
1,896
-1,714
-241
Prepaid expenses and other assets
-2,136
340
685
1,721
Accounts payable
-3,427
-17,973
19,247
-1,306
Accrued expenses and other liabilities
216
-2,803
5,090
118
Deferred revenue
-273
-272
-272
-273
Net cash used for operating activities
-9,441
-14,806
-8,469
-12,649
Capital expenditures
212
52
85
235
Net cash used for investing activities
-212
-52
-85
-235
Proceeds from common stock issued under public equity offering-atm, net
-79
4,759
21,194
-
Proceeds from common stock issued under public equity offering-At The Market Offering
-
-
-
-9
Proceeds from common stock issued under public equity offering, net
-
-
79,460
-
Proceeds from issuance of long-term debt under the credit agreement
54,337
-
-
-
Proceeds from common stock issued under public equity offering-Public Equity Offering
-
-
-
79,728
Proceeds from exercise of warrants, net
-
-
0
1,430
Proceeds from issuance of warrants under the credit agreement
663
-
-
-
Proceeds from shares issued under employee stock purchase plan
70
-
60
0
Proceeds from exercise of stock options, net
26
1
924
339
Repayment of debt principal - 13.5 notes
44,992
8
26
-
Debt exit fee paid - 13.5 notes
2,000
-
-
-
Premium paid to retire debt - 13.5 notes
3,887
-
-
-
Payments for financing costs
3,449
-
-
7
Payments for lease liabilities
18
-
-
-
Payments for royalty obligations
0
0
0
11
Payments for taxes on share-based compensation, net
3,241
329
18
70
Net cash provided by financing activities
-2,591
4,423
660
81,411
Net decrease in cash and cash equivalents
-12,244
-10,435
-7,894
68,527
Cash and cash equivalents at beginning of period
110,734
121,169
129,063
71,546
Cash and cash equivalents at end of period
98,490
110,734
121,169
129,063
Cash payments for interest
2,269
-
-
-
Non-cash investing activities capital expenditures in accounts payable
43
-
-
-
Non-cash financing activities term loan facility costs in accounts payable
461
-
-
-
Interest rate (as a percent)
0
-
-
-
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net decrease in cash
and cash...
-$12,244K
(-11.21%↓ Y/Y)
Loss on
extinguishment of debt
-$11,683K
Share-based compensation
$2,895K
(-16.59%↓ Y/Y)
Prepaid expenses and
other assets
-$2,136K
(31.19%↑ Y/Y)
Amortization of debt issuance
costs and discounts
$1,767K
(-67.86%↓ Y/Y)
Issuance of warrants
under the purchase...
$916K
Inventories
-$706K
(-133.93%↓ Y/Y)
Accrued expenses and
other liabilities
$216K
(109.93%↑ Y/Y)
Depreciation, amortization,
and impairment
$136K
(-51.25%↓ Y/Y)
Other, net
-$43K
(-490.91%↓ Y/Y)
Proceeds from issuance of
long-term debt under the...
$54,337K
Proceeds from issuance of
warrants under the credit...
$663K
Proceeds from shares
issued under employee...
$70K
(40.00%↑ Y/Y)
Proceeds from exercise of
stock options, net
$26K
(271.43%↑ Y/Y)
Net cash used for
operating activities
-$9,441K
(69.85%↑ Y/Y)
Net cash provided by
financing activities
-$2,591K
(-112.61%↓ Y/Y)
Net cash used for
investing activities
-$212K
(12.40%↑ Y/Y)
Canceled cashflow
$20,498K
Canceled cashflow
$55,096K
Net loss
-$22,864K
(37.32%↑ Y/Y)
Repayment of debt
principal - 13.5 notes
$44,992K
Capital expenditures
$212K
(-12.40%↓ Y/Y)
Accounts payable
-$3,427K
(-316.62%↓ Y/Y)
Trade and other
receivables, net
$2,459K
(-45.06%↓ Y/Y)
something is missing
-$916K
Deferred revenue
-$273K
(-950.00%↓ Y/Y)
Premium paid to retire
debt - 13.5 notes
$3,887K
Payments for financing
costs
$3,449K
(24535.71%↑ Y/Y)
Payments for taxes on
share-based compensation,...
$3,241K
(348.89%↑ Y/Y)
Debt exit fee paid -
13.5 notes
$2,000K
Proceeds from common
stock issued under...
-$79K
Payments for lease
liabilities
$18K
Buy us a coffee